Press releases

Media contact: Stéphanie Bardon – communication@genethon.fr – 01.69.47.12.78

Creation of YposKesi

(read more)

Genethon and CRISPR Therapeutics announce Research Collaboration

(read more)

Genethon: a gene therapy drug being tested in the US

(read more)

ASGCT 18th Annual Meeting 2015: Ana Buj Bello receives the Outstanding New Investigator Award

(read more)

Selecta and Genethon Collaborate to Create Next Generation Gene Therapies Using Selecta’s Synthetic Vaccine Particle Platform

(read more)

Evidence of efficacy of gene therapy in rodents affected by a rare genetic liver disease, Crigler-Najjar syndrome

(read more)

Généthon, Winner of the World Innovation Competition 2030

(read more)

New gene therapy success in a rare disease of the immune system: Wiskott-Aldrich syndrome

(read more)

Effectiveness of innovative gene therapy treatment demonstrated in canine model of Duchenne muscular dystrophy

(read more)

GENETHON and ESTEVE announce agreement to manufacture the gene therapy for the treatment of Sanfilippo Syndrome

(read more)

Audentes Therapeutics and Genethon Announce Agreement to Develop Treatment for Severe Genetic Disease X‐Linked Myotubular Myopathy

(read more)

Efficacy of gene therapy demonstrated in canine and murine models of myotubular myopathy

(read more)

Généthon, the French AFM-Telethon laboratory, becomes the first not-for-profit to obtain authorization from ANSM to be a pharmaceutical manufacturer

(read more)

The European charity Myotubular Trust is supporting Généthon in developing gene therapy for myotubular myopathy

(read more)

Genethon receives approval from the UK medicine regulatory agency to start a new clinical trial for an inherited immune deficiency: chronic granulomatous disease

(read more)